SCHEMBL14218065

SCHEMBL14218065

CCN1CCN(C(=O)CCC(=O)c2ccc(-c3ccccc3)cc2)CC1

nearest known ligand 0.62

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.62
NCOA3 Q9Y6Q9 1/20 0.62
HSD11B1 P28845 1/20 0.56
L3MBTL1 Q9Y468 2/20 0.55
HPGD P15428 1/20 0.55
FFAR1 O14842 1/20 0.53
LMNA P02545 1/20 0.53
CYP1A2 P05177 1/20 0.53
RAB9A P51151 1/20 0.53
HIF1A Q16665 1/20 0.53
HTT P42858 1/20 0.52
ALDH1A1 P00352 1/20 0.52
HRH3 Q9Y5N1 5/20 0.50
MAPT P10636 1/20 0.50
MEN1 O00255 1/20 0.50
KMT2A Q03164 1/20 0.50
ACHE P22303 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4380633 0.83 RAB9A (0.60) SMN1; SMN2L3MBTL1HPGDFFAR1LMNA
SCHEMBL4381243 0.78 HRH3 (0.73) HIF1AHTTALDH1A1HRH3MAPT
SCHEMBL4386212 0.77 HRH3 (0.72) HIF1AALDH1A1HRH3MAPTKMT2A
SCHEMBL4382306 0.77 MAPT (0.55) SMN1; SMN2LMNAALDH1A1MAPTMEN1
Hydrochloric Acid SCHEMBL4377741 0.76 MAPT (0.54) SMN1; SMN2LMNAALDH1A1MAPTMEN1
SCHEMBL10162567 0.76 HSD11B1 (0.72) HSD11B1L3MBTL1RAB9AALDH1A1MAPT
SCHEMBL2835721 0.75 ACHE (0.62) L3MBTL1HRH3ACHE
SCHEMBL17549664 0.75 KMT2A (0.71) ALDH1A1MAPTKMT2A
SCHEMBL8534233 0.74 SMN1; SMN2 (0.84) SMN1; SMN2L3MBTL1HPGDFFAR1LMNA
SCHEMBL7169669 0.73 ALDH1A1 (0.63) SMN1; SMN2HPGDRAB9AALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080113968-A1 Substituted piperazines and diazepanes NOVO NORDISK A/S (DK) 2008-05-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080113968-A1 Substituted piperazines and diazepanes HRH3, HRH4, HRH1 SMN1; SMN2 2684/4885NCOA3 679/4885HSD11B1 2071/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.